NCT03932331 2026-01-29Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell MalignanciesAstraZenecaPhase 1/2 Active not recruiting105 enrolled 34 charts
NCT04855695 2026-01-21Avo In R/R And Previously Untreated MCLDana-Farber Cancer InstitutePhase 1/2 Recruiting72 enrolled